Polymyxin B sulphate protects cats against the haemodynamic and metabolic effects of E. coli endotoxin

British Journal of Pharmacology
B HughesJ R Parratt

Abstract

1 The intravenous administration of E. coli endotoxin (2 mg/kg) in cats anaesthetized with pentobarbitone resulted in an initial acute increase in right atrial pressure and a transient systemic hypotension. Later (from 1 h onwards) there was a progressive decrease in cardiac output, a reduced right atrial filling pressure, systemic hypotension and a profound metabolic acidosis (lactate of 30 +/- 1 mg/100 ml at 5 h compared with 5.1 +/- 0.5 mg/100 ml pre-endotoxin). Only one of eight animals so treated survived 8 h. 2 Polymyxin B sulphate, given intravenously (1 min before endotoxin) as a bolus injection (5 mg/kg) followed by a continuous intravenous infusion (additional 5 mg/kg given over a 30 min period) prevented the endotoxin-induced pulmonary (right atrial) hypertension but not the acute systemic hypotension. 3 Polymyxin B sulphate reduced the delayed haemodynamic effects of endotoxin (systemic hypotension, decrease in cardiac output); all the eight animals so treated survived 8 h compared with only 1/8 of the controls. 4 Polymyxin B did not prevent the initial (1-3 h) and marked metabolic acidosis following endotoxin; however, after 3 h, arterial lactate levels returned towards control whereas in the endotoxin-alone group ...Continue Reading

References

May 1, 1979·Canadian Anaesthetists' Society Journal·C LeeR L Katz
Oct 1, 1976·Immunochemistry·D C Morrison, D M Jacobs
Oct 1, 1977·The Journal of Infectious Diseases·R M BannatyneW D Biggar
Nov 1, 1977·Canadian Journal of Microbiology·R M BannatyneR Cheung
Jan 1, 1979·Pediatric Research·J J Corrigan, J F Kiernat
Nov 1, 1979·British Journal of Anaesthesia·Y Z Sohn, R L Katz
Sep 1, 1979·Canadian Journal of Microbiology·R M Bannatyne, R Cheung
Apr 1, 1967·Journal of Bacteriology·D Rifkind
Oct 1, 1967·Journal of Chromatography·M R Howlett, G B Selzer
Nov 1, 1969·Journal of Bacteriology·J Lopes, W E Inniss
Mar 1, 1957·Proceedings of the Society for Experimental Biology and Medicine·B W GRUNBAUMD GLICK
Jun 1, 1955·British Journal of Pharmacology and Chemotherapy·S R BUSHBY, A F GREEN

❮ Previous
Next ❯

Citations

Jan 1, 1995·Veterinary Research Communications·C Justus, J F Quirke
Feb 17, 2010·Journal of Feline Medicine and Surgery·Claire R SharpCarol R Reinero
Jul 29, 1999·The Journal of Peptide Research : Official Journal of the American Peptide Society·S K SharmaK W Bair
Sep 1, 1989·Antimicrobial Agents and Chemotherapy·R L DannerJ E Parrillo
Jun 1, 1994·Antimicrobial Agents and Chemotherapy·J M PrinsP Speelman
May 1, 1996·Archives of Disease in Childhood·C Dezateux, S Godward
Oct 1, 1987·Burns, Including Thermal Injury·J P WaymackG D Warden
Jan 29, 2013·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Yuta NanjoKeizo Yamaguchi
Dec 25, 2010·The Lancet Infectious Diseases·B Davies, J Cohen
Jul 28, 2016·Journal of Veterinary Pharmacology and Therapeutics·A H Werners
Dec 1, 1985·The British Journal of Surgery·J A PainM E Bailey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis
K HanasawaS Nishiumi
Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
Hidehiko KushiKatsuhisa Tanjoh
© 2021 Meta ULC. All rights reserved